Tarrytown-headquartered Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is collaborating with Celularity Inc. (NASDAQ:CELU) a Florham Park, New Jersey-based biotechnology company, in a multi-year agreement focused on allogeneic cell therapy candidates.